Product image of Аймафикс (Human Coagulation Factor Ix) supplied by GNH India

Аймафикс

Active Ingredient:
Human Coagulation Factor Ix
Origin:
EU

Аймафикс (Human Coagulation Factor Ix)

Аймафикс is a human coagulation factor IX product used to manage bleeding disorders like hemophilia B. This intravenous therapy helps replace missing clotting factors to support normal blood clotting processes. Suitable for patients requiring factor IX replacement therapy.

Manufacturer / TM Owner

Kedrion S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Аймафикс is primarily used to treat and prevent bleeding episodes in patients with hemophilia B, a condition where the blood lacks sufficient clotting factor IX. It may also be used before medical procedures to reduce bleeding risk. This therapy helps maintain adequate clotting function in affected individuals.

Side Effects

  • When administered, Аймафикс works by temporarily increasing factor IX levels in the bloodstream to support the clotting process. Users may experience improved bleeding control and reduced frequency of spontaneous bleeds. Effects vary based on individual response and dosing.

Precautions & Warnings

  • Store Аймафикс as directed, typically refrigerated but protected from freezing. Avoid exposure to extreme temperatures or direct sunlight. Always check the product for clarity and particles before use. Follow healthcare provider instructions for proper handling and administration.

Avoid Interactions

  • No specific drug interactions are widely documented for Аймафикс. However, concurrent use of other blood products or medications affecting blood clotting may require careful monitoring. Always inform healthcare providers about all medications being taken to assess potential risks.

Frequently Asked Questions

Аймафикс is used to treat and prevent bleeding in patients with hemophilia B by replacing missing clotting factor IX.

Аймафикс is given as an intravenous injection, typically by a healthcare professional.

Availability may vary by region; consult a licensed pharmacy or healthcare provider for purchasing options.

Ensure proper storage and check the product for clarity before use; follow healthcare provider guidance.

Possible effects may include headache, nausea, or injection site reactions; report any concerns to a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Ix

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT